Pharma Executive Makes a Fortune off of Botched Vaccines

The CEO of Emergent Biosolutions sold $10 million worth of stock before it fell 50% due to reports of vaccine production problems.

The CEO of Emergent Biosolutions sold $10 million worth of stock before it fell 50% due to reports of vaccine production problems.